Amphastar Pharma Financials - Benzinga

Amphastar Pharmaceuticals Inc

AMPHNASDAQ

Trade with Public

Trade with Public

$21.54

-0.06-0.28%

마지막 업데이트: Aug 24, 8:35 AM

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 비교 옵션 주식 보고서

Amphastar Pharma Financials

Amphastar Pharma (AMPH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Amphastar Pharma Q2 Adj. EPS $0.91 Beats $0.62 Estimate, Sales $183.903M Beat $182.055M Estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.62 by 46.77 percent. This is a 7.06 percent increase over earnings of $0.85 per share from

Benzinga Newsdesk

PRO
Amphastar Pharma Q1 Adj. EPS $0.42 Misses $0.70 Estimate, Sales $171.171M Miss $173.392M Estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.42 per share which missed the analyst consensus estimate of $0.70 by 40.85 percent. This is a 43.24 percent decrease over earnings of $0.74 per share from

Benzinga Newsdesk

Earnings Summary: Amphastar Pharma Q4

Benzinga Insights

PRO
Amphastar Pharma Q4 Adj. EPS $0.73 Misses $0.92 Estimate, Sales $183.105M Miss $190.480M Estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.73 per share which missed the analyst consensus estimate of $0.92 by 20.82 percent. This is a 20.65 percent decrease over earnings of $0.92 per share from

Benzinga Newsdesk

Earnings Scheduled For February 26, 2026

Benzinga Insights

Insights Ahead: Amphastar Pharma's Quarterly Earnings

Benzinga Insights

© 2026 Benzinga | All Rights Reserved